Related Experiment Video
Updated: Jul 31, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
L W Castellani1, A Weinreb, J Bodnar
1Department of Medicine, University of California, Los Angeles 90095, USA.
Nature Genetics
|April 16, 1998
Summary
A novel mouse model, HcB-19, displays key features of familial combined hyperlipidaemia (FCHL), including high triglyceride and cholesterol levels. This genetic discovery aids in understanding the complex causes of FCHL and premature coronary artery disease.
Area of Science:
- Genetics
- Cardiovascular Disease
- Metabolic Disorders
Background:
- Familial combined hyperlipidaemia (FCHL) is a common genetic disorder causing high cholesterol and triglycerides.
- FCHL is a major risk factor for premature coronary artery disease (CAD).
- The genetic basis of FCHL remains largely unknown.
Purpose of the Study:
- To identify a genetic cause for hyperlipidaemia using an animal model.
- To characterize a novel mouse strain exhibiting FCHL-like traits.
- To map the genetic locus responsible for hyperlipidaemia in mice.
Main Methods:
- Identification and phenotypic characterization of the HcB-19 mouse strain.
- Analysis of plasma lipid profiles (triglyceride, cholesterol, apolipoprotein B).
- Genetic mapping of the hyperlipidaemia gene (Hyplip1) to mouse chromosome 3.
Main Results:
- The HcB-19 mouse strain exhibits hypertriglyceridaemia, hypercholesterolaemia, and elevated apolipoprotein B.
- HcB-19 mice show increased secretion of very low density lipoproteins (VLDL).
- The Hyplip1 gene was mapped to mouse chromosome 3, syntenic to human chromosome 1q21-q23.
Conclusions:
- The HcB-19 mouse is a valuable model for studying FCHL.
- The identified genetic locus provides a new target for FCHL research.
- Findings suggest a conserved genetic basis for FCHL between mice and humans.
Related Concept Videos
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...